Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
1,005.00
+8.00 (0.80%)
At close: Jun 16, 2025

TPE:6919 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Market Capitalization
154,14594,36523,5407,528--
Upgrade
Market Cap Growth
238.59%300.87%212.69%---
Upgrade
Enterprise Value
144,60384,68522,6946,297--
Upgrade
Last Close Price
997.00615.00191.2561.13--
Upgrade
PS Ratio
3809.062123.71604.64587.23--
Upgrade
PB Ratio
16.129.736.296.47--
Upgrade
P/TBV Ratio
16.129.736.296.47--
Upgrade
EV/Sales Ratio
-1905.86582.91491.18--
Upgrade
Debt / Equity Ratio
0.000.000.010.030.062.81
Upgrade
Asset Turnover
0.010.010.020.010.030.05
Upgrade
Inventory Turnover
2.907.045.992.252.412.89
Upgrade
Quick Ratio
124.65183.4250.4823.0415.001.45
Upgrade
Current Ratio
125.22184.0250.8123.4115.261.72
Upgrade
Return on Equity (ROE)
-8.34%-8.76%-19.92%-31.64%-64.89%-528.22%
Upgrade
Return on Assets (ROA)
-6.61%-6.59%-12.68%-20.53%-30.68%-33.22%
Upgrade
Return on Capital (ROIC)
-6.71%-6.65%-12.96%-21.32%-33.58%-40.80%
Upgrade
Earnings Yield
-0.35%-0.62%-2.08%-3.80%--
Upgrade
FCF Yield
-0.32%-0.56%-1.84%-3.41%--
Upgrade
Buyback Yield / Dilution
-20.83%-15.40%-5.77%-27.35%-23.49%-6.52%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.